𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Platelet monoamine oxidase in Parkinson patients: effect of L-deprenyl therapy

✍ Scribed by D. H. Lee; M. Mendoza; M. T. Dvorozniak; E. Chung; M. H. van Woert; M. D. Yahr

Book ID
105512414
Publisher
Springer
Year
1989
Tongue
English
Weight
375 KB
Volume
1
Category
Article
ISSN
1435-1463

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A dose-ranging study of selegiline in pa
A dose-ranging study of selegiline in patients with Parkinson's disease: Effect on platelet monoamine oxidase activity
✍ Nathalie Andreu; Christine Damase-Michel; Jean-Michel Senard; Olivier Rascol; Pr πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 337 KB πŸ‘ 1 views

## Abstract A dose‐ranging study of selegiline was performed in patients with Parkinson's disease to determine the minimal dosage of the drug able to inhibit β‰₯95% of platelet monoamine oxidase (MAO) activity. Different doses of selegiline (5 or 10 mg daily, 10 or 20 mg weekly) were studied in four